Sequence Database
For Research Use Only. Not for Human or Veterinary Use.
Overview
A per-compound sequence profile for every entry in this database — one-letter/three-letter notation, length, terminus chemistry, modifications, disulfide bridges, molecular formula, average MW and class — grouped by research category, followed by a length-sorted master summary. Small molecules and mixtures are profiled by structure/composition instead of an invented sequence.
Sequence Notation Guide
| Notation | Example | Meaning |
|---|---|---|
| 3-letter code | Gly-His-Lys | Standard IUPAC three-letter amino-acid codes, hyphen-separated |
| 1-letter code | GHK | Standard IUPAC single-letter amino-acid codes |
| H- | H-Gly-… | Free (unmodified) N-terminal amine |
| Ac- | Ac-Glu-… | N-terminal acetylation |
| Pal- | Pal-Lys-… | N-terminal palmitoylation (C16 fatty-acid cap) |
| -OH | …-Lys-OH | Free C-terminal carboxylic acid |
| -NH₂ | …-Arg-NH₂ | C-terminal amidation |
| D-Xxx | D-Phe | D-amino acid (mirror-image residue), used for protease resistance |
| Aib | Aib-His-… | α-Aminoisobutyric acid — a non-standard stabilising residue |
| Dmt | Dmt | 2′,6′-Dimethyl-L-tyrosine — a non-standard aromatic residue (SS-31) |
| Cys / disulfide bridge | Cys¹–Cys⁶ | Cysteine residue; two cysteines can form a covalent disulfide (-S-S-) bond |
GLP-1 Receptor Agonists
Tirzepatide
- Sequence / structure
- 39-amino-acid peptide (GIP-based) + C20 fatty-diacid on a PEG linker
- Length
- 39 aa
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- MW (average)
- 4813.45
- Class
- GIP/GLP-1 dual agonist
Retatrutide
- Sequence / structure
- 39-amino-acid peptide (GIP-based) + C20 fatty-diacid conjugation
- Length
- 39 aa
- Molecular formula
- ≈ C₂₂₈H₃₅₄N₄₆O₆₈
- MW (average)
- ≈ 4840.58
- Class
- GIP/GLP-1/GCGR triagonist
Semaglutide
- Sequence / structure
- 31-aa GLP-1 analogue; Aib at position 8; C18 fatty-diacid at Lys26
- Length
- 31 aa
- Molecular formula
- C₁₈₇H₂₉₁N₄₅O₅₉
- MW (average)
- 4113.58
- Class
- GLP-1 receptor agonist
Cosmetic & Topical Peptides
GHK-Cu
- Sequence
- H-Gly-His-Lys-OH (+ Cu²⁺)
- Length
- 3 aa
- N-terminus
- Free amine (H-)
- C-terminus
- —
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- C₁₄H₂₄N₆O₄·Cu
- MW (average)
- ≈ 403.9
- Class
- Copper tripeptide (matrikine)
Matrixyl
- Sequence
- Pal-Lys-Thr-Thr-Lys-Ser-OH
- Length
- 5 aa
- N-terminus
- Palmitoylated (Pal-)
- C-terminus
- Free acid (-OH)
- Modifications
- N-terminal palmitoylation (C16 fatty-acid cap)
- Disulfide bridges
- None
- Molecular formula
- C₃₉H₇₅N₇O₁₀
- MW (average)
- 802.06
- Class
- Palmitoyl matrikine
Argireline
- Sequence
- Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂
- Length
- 6 aa
- N-terminus
- Acetylated (Ac-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- N-terminal acetylation; C-terminal amidation
- Disulfide bridges
- None
- Molecular formula
- C₃₄H₆₀N₁₄O₁₂S
- MW (average)
- 888.47
- Class
- Neuromodulatory peptide
Matrixyl 3000
- Sequence
- Pal-Gly-His-Lys-OH + Pal-Gly-Gln-Pro-Arg-OH (two-peptide blend)
- Length
- 3 + 4 aa
- N-terminus
- Palmitoylated (Pal-)
- C-terminus
- —
- Modifications
- N-terminal palmitoylation (C16 fatty-acid cap)
- Disulfide bridges
- None
- Molecular formula
- C₃₀H₅₃N₇O₆ + C₃₀H₅₂N₈O₇
- MW (average)
- 673.8 + 520.7
- Class
- Dual palmitoyl matrikine
SNAP-8
- Sequence
- Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂
- Length
- 8 aa
- N-terminus
- Acetylated (Ac-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- N-terminal acetylation; C-terminal amidation
- Disulfide bridges
- None
- Molecular formula
- C₄₃H₇₃N₁₅O₁₆S
- MW (average)
- 1074.30
- Class
- Neuromodulatory peptide
Tissue Repair & Regenerative
BPC-157
- Sequence
- H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH
- Length
- 15 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- C₆₂H₉₈N₁₆O₂₂
- MW (average)
- 1419.52
- Class
- Gastric pentadecapeptide
TB-500 (Ac-SDKP)
- Sequence
- Ac-Ser-Asp-Lys-Pro (active fragment of full 43-aa Thymosin Beta-4)
- Length
- 4 aa
- N-terminus
- Acetylated (Ac-)
- C-terminus
- —
- Modifications
- N-terminal acetylation
- Disulfide bridges
- None
- Molecular formula
- C₂₀H₃₂N₄O₉
- MW (average)
- 500.52
- Class
- Thymosin β4 fragment
Mitochondrial & Metabolic
MOTS-c
- Sequence
- H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH
- Length
- 16 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- — (2 Met)
- MW (average)
- ≈ 2174.6
- Class
- Mitochondrial-derived peptide
SS-31 (Elamipretide)
- Sequence
- H-D-Arg-Dmt-Lys-Phe-NH₂ (Dmt = 2′,6′-dimethyl-L-tyrosine)
- Length
- 4 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- C-terminal amidation; 1 D-amino-acid substitution (protease resistance); Dmt (2′,6′-dimethyl-L-tyrosine) substitution
- Disulfide bridges
- None
- Molecular formula
- C₃₄H₅₈N₁₀O₆
- MW (average)
- 639.81
- Class
- Cardiolipin-targeting tetrapeptide
Humanin
- Sequence
- H-Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH
- Length
- 24 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- 1 free cysteine present (potential dimerization site)
- Molecular formula
- — (Met + Cys)
- MW (average)
- ≈ 2687.2
- Class
- Mitochondrial-derived peptide
AOD-9604
- Sequence
- H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH
- Length
- 16 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- 2 cysteines present (see profile page for bridge assignment)
- Molecular formula
- — (disulfide)
- MW (average)
- ≈ 1815.1
- Class
- Modified hGH fragment
Growth Factors & Signaling
MK-677 (Ibutamoren)
- Sequence / structure
- Small molecule (spiro-indoline) — not a peptide sequence
- Length
- — (non-peptide)
- Molecular formula
- C₂₇H₃₆N₄O₅S
- MW (average)
- 528.66
- Class
- Non-peptide GHSR agonist
Ipamorelin
- Sequence
- H-Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- Length
- 5 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- C-terminal amidation; 2 D-amino-acid substitutions (protease resistance); Aib (α-aminoisobutyric acid) substitution
- Disulfide bridges
- None
- Molecular formula
- C₃₈H₄₉N₉O₅
- MW (average)
- 711.86
- Class
- Pentapeptide GHSR agonist
GHRP-2
- Sequence
- H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂
- Length
- 6 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- C-terminal amidation; 3 D-amino-acid substitutions (protease resistance)
- Disulfide bridges
- None
- Molecular formula
- C₄₅H₅₅N₉O₆
- MW (average)
- ≈ 817.9
- Class
- Hexapeptide GHSR agonist
GHRP-6
- Sequence
- H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
- Length
- 6 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- C-terminal amidation; 2 D-amino-acid substitutions (protease resistance)
- Disulfide bridges
- None
- Molecular formula
- C₄₆H₅₆N₁₂O₆
- MW (average)
- 873.01
- Class
- Hexapeptide GHSR agonist
CJC-1295
- Sequence / structure
- Mod GHRH(1–29): D-Ala²/Gln⁸/Ala¹⁵/Leu²⁷ substitutions + C-terminal Lys–DAC
- Length
- 29–30 aa
- Molecular formula
- — (GHRH + DAC)
- MW (average)
- ≈ 3647 (DAC)
- Class
- GHRH analogue (DAC)
Sermorelin
- Sequence
- H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
- Length
- 29 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Amidated (-NH₂)
- Modifications
- C-terminal amidation
- Disulfide bridges
- None
- Molecular formula
- C₁₄₉H₂₄₆N₄₄O₄₂S
- MW (average)
- ≈ 3357.9
- Class
- GHRH(1–29) fragment
Cognitive & Neuro Regulation
Semax
- Sequence
- H-Met-Glu-His-Phe-Pro-Gly-Pro-OH
- Length
- 7 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- C₃₇H₅₁N₉O₁₀S
- MW (average)
- ≈ 813.9
- Class
- ACTH(4–10) analogue
Selank
- Sequence
- H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH
- Length
- 7 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- C₃₃H₅₇N₁₁O₉
- MW (average)
- ≈ 751.9
- Class
- Tuftsin analogue
Noopept
- Sequence / structure
- Small molecule (N-phenylacetyl-L-prolylglycine ethyl ester) — not a peptide sequence
- Length
- — (small molecule)
- Molecular formula
- C₁₇H₂₂N₂O₄
- MW (average)
- 342.39
- Class
- Nootropic small molecule
Cerebrolysin
- Sequence / structure
- Peptide mixture — no single sequence (see composition profile)
- Length
- — (mixture)
- Molecular formula
- — (mixture)
- MW (average)
- 120–10,000
- Class
- Brain-peptide cocktail
Sleep & Pineal Peptides
Epitalon
- Sequence
- H-Ala-Glu-Asp-Gly-OH
- Length
- 4 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- C₁₄H₂₂N₄O₉
- MW (average)
- ≈ 390.4
- Class
- Pineal tetrapeptide
Pinealon
- Sequence
- H-Glu-Asp-Arg-OH
- Length
- 3 aa
- N-terminus
- Free amine (H-)
- C-terminus
- Free acid (-OH)
- Modifications
- None noted
- Disulfide bridges
- None
- Molecular formula
- C₁₅H₂₆N₆O₈
- MW (average)
- ≈ 418.4
- Class
- Pineal tripeptide
Sequence Length Summary
| Compound | Length | Sequence | Category |
|---|---|---|---|
| GHK-Cu | 3 aa | GHK (Cu complex) | Cosmetic & Topical Peptides |
| Matrixyl 3000 | 3 aa | Pal-GHK + Pal-GQPR | Cosmetic & Topical Peptides |
| Pinealon | 3 aa | EDR | Sleep & Pineal Peptides |
| TB-500 (Ac-SDKP) | 4 aa | Ac-SDKP | Tissue Repair & Regenerative |
| SS-31 (Elamipretide) | 4 aa | D-Arg-Dmt-Lys-Phe-NH₂ | Mitochondrial & Metabolic |
| Epitalon | 4 aa | AEDG | Sleep & Pineal Peptides |
| Matrixyl | 5 aa | Pal-KTTKS | Cosmetic & Topical Peptides |
| Ipamorelin | 5 aa | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ | Growth Factors & Signaling |
| Argireline | 6 aa | Ac-EEMQRR-NH₂ | Cosmetic & Topical Peptides |
| GHRP-2 | 6 aa | D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ | Growth Factors & Signaling |
| GHRP-6 | 6 aa | His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂ | Growth Factors & Signaling |
| Semax | 7 aa | MEHFPGP | Cognitive & Neuro Regulation |
| Selank | 7 aa | TKPRPGP | Cognitive & Neuro Regulation |
| SNAP-8 | 8 aa | Ac-EEMQRRAD-NH₂ | Cosmetic & Topical Peptides |
| BPC-157 | 15 aa | GEPPPGKPADDAGLV | Tissue Repair & Regenerative |
| MOTS-c | 16 aa | MRWQEMGYIFYPRKLR | Mitochondrial & Metabolic |
| AOD-9604 | 16 aa | YLRIVQCRSVEGSCGF | Mitochondrial & Metabolic |
| Humanin | 24 aa | MAPRGFSCLLLLTSEIDLPVKRRA | Mitochondrial & Metabolic |
| CJC-1295 | 29 aa | Mod GHRH(1–29) + DAC | Growth Factors & Signaling |
| Sermorelin | 29 aa | GHRH(1–29)-NH₂ | Growth Factors & Signaling |
| Semaglutide | 31 aa | 31-aa GLP-1 analogue | GLP-1 Receptor Agonists |
| Tirzepatide | 39 aa | 39-aa (GIP/GLP-1) | GLP-1 Receptor Agonists |
| Retatrutide | 39 aa | 39-aa (triple) | GLP-1 Receptor Agonists |
Not length-ranked above (non-peptide small molecules or mixtures): MK-677 (Ibutamoren), Noopept, Cerebrolysin. Sequences shown are checked against each compound’s own profile page.
Need research-grade peptides?
HPLC-verified, COA per batch. Tell us the quantity you need.
